Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$29.80K$29.80Kderived−24.3% vs Q4 2015 Net Income-$1.07M-$1.07MderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived-$165,084N/M Operating Incomederived-$574,103N/M Operating Cash Flowderived-$388,348N/M Free Cash Flowderived-$390,818N/M Margins · derivedGross margin-554.0%−632.1 pt vs Q4 2015
Operating margin-1926.5%−502.7 pt vs Q4 2015
Net margin-3606.9%
ended Dec 31, 2016 · filed Apr 17, 2017 · 107 d after period end